Keywords: اتانرسپت ; adalimumab; etanercept; indirect comparison; psoriasis;
مقالات ISI اتانرسپت (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: اتانرسپت ; Freeze drying; Annealing; Etanercept; Mannitol; Glycine; Biophysical properties;
Keywords: اتانرسپت ; AZA; azathioprine; ADA; adalimumab; CYA; cyclosporine A; CYX; cyclophosphamide; ETN; etanercept; FK; tacrolimus; IFX; infliximab; IS; immunosuppressant; LFM; leflunomide; MMF; mycophenolate mofetil; MTX; methotrexate; RTX; rituximab; TAK; Takayasu's Arter
Keywords: اتانرسپت ; Ischemia-reperfusion; Ischemic preconditioning; Delayed neuronal death; Tumor necrosis factor-α; Tumor necrosis factor receptor; Etanercept;
Keywords: اتانرسپت ; adalimumab; etanercept; non-TNF-α biologics; real-world effectiveness; rheumatoid arthritis; TNF-α inhibitors;
Keywords: اتانرسپت ; Adalimumab; Etanercept; Omalizumab; Insulin; Injection site reactions; Systemic hypersensitivity reactions; MoAbs; TNF-α inhibitors;
Keywords: اتانرسپت ; MTX; methotrexate; TNF; tumor necrosis factor; IL; interleukin; CTLA4; cytotoxic T-lymphocyte antigen 4; IFX; infliximab; ADA; adalimumab; GLM; golimumab; CZP; certolizumab pegol; ETN; etanercept; TCZ; tocilizumab; ABA; abatacept; RTX; rituximab; UTK; ust
Keywords: اتانرسپت ; Carbopol hydrogel; Etanercept; HaCaT keratinocytes; Human skin permeation; Methotrexate; Psoriatic skin; Solid lipid nanoparticles;
Keywords: اتانرسپت ; ADA; adalimumab; AEs; adverse events; AZA; azathioprine; CI; confidence interval; Cy; cyclosporine; CNS; central nervous system; CS; corticosteroids; CYC; cyclophosphamide; CZP; certolizumab pegol; ePOST; Extrapulmonary Physician Organ Severity Tool; ETN;
Keywords: اتانرسپت ; Rheumatoid arthritis; Conjugated pneumococcal vaccine; PCV13; Etanercept; Protective antibody level;
Keywords: اتانرسپت ; Etanercept; Skin disease; TreatmentEtanercept; Enfermedad cutánea; Tratamiento
Keywords: اتانرسپت ; etanercept; long-term safety; open-label; pediatric population; plaque psoriasis; AE; adverse event; CDC; Centers for Disease Control and Prevention; FDA; Food and Drug Administration; HRQOL; health-related quality of life; JIA; juvenile idiopathic arthri
Keywords: اتانرسپت ; Arginine oxidation; Protein denaturant; Protein aggregation; DSC; Etanercept; NOx
Keywords: اتانرسپت ; cost; daily clinical practice; efficacy; etanercept; aque-type psoriasis;
Keywords: اتانرسپت ; Psoriasis; Biosimilar; Biologic; Clinical trials; Interchangeability; Substitution; Legislation; Infliximab; Etanercept; AdalimumabPsoriasis; Biosimilar; Biológico; Ensayos clínicos; Intercambiabilidad; Sustitución; Legislación; Infliximab; Etanercept; Ad
Keywords: اتانرسپت ; RA; rheumatoid arthritis; IFX; infliximab; ETN; etanercept; ADCC; antibody-dependent cellular cytotoxicity; CDC; complement-dependent cytotoxicity; CCP; cyclic citrullinated peptide; RF; rheumatoid factor; MMP-3; matrix-metalloproteinase-3; DAS28-ESR; dis
Keywords: اتانرسپت ; Streptozotocin; Rat dementia model; Thalidomide; Etanercept; InfliximabaCSF, artificial cerebrospinal fluid; AD, Alzheimer's disease; Aβ, amyloid beta; BBB, blood–brain barrier; CNS, central nervous system; DAB, diaminobenzidine; H&E, hematoxylin and eosi
Keywords: اتانرسپت ; adalimumab; biologics switch; etanercept; PASI (Psoriasis Area and Severity Index); psoriasis; ustekinumb
Keywords: اتانرسپت ; acne inversa; adalimumab; anakinra; biologics; etanercept; hidradenitis suppurativa; infliximab; treatment; tumor necrosis factor–alfa; ustekinumab
Keywords: اتانرسپت ; etanercept; health-related quality of life; rheumatoid arthritis; treatment comparison;
Keywords: اتانرسپت ; Terapia biológica; Reducción de dosis; Adalimumab; Etanercept; Infliximab; UstekinumabBiologic therapy; Dose reduction; Adalimumab; Etanercept; Infliximab; Ustekinumab
Keywords: اتانرسپت ; Biologic therapy; Dose reduction; Adalimumab; Etanercept; Infliximab; UstekinumabTerapia biológica; Reducción de dosis; Adalimumab; Etanercept; Infliximab; Ustekinumab
Keywords: اتانرسپت ; adalimumab; biologics; etanercept; infliximab; monitoring; psoriasis; psoriatic arthritis; safety; screening; ustekinumab; AAD; American Academy of Dermatology; ALP; alkaline phosphatase; ALT; alanine transaminase; ANA; antinuclear antibody; AST; aspartat
Keywords: اتانرسپت ; Methotrexate; Hepatotoxicity; Nephrotoxicity; Etanercept; Aminoguanidine
Keywords: اتانرسپت ; Biologics; Dermatology; Etanercept; Adalimumab; Infliximab; Ustekinumab; Secukinumab; IVIG;
Keywords: اتانرسپت ; Etanercept; Oxidation; Amino acids; Methionine; Histidine; Biophysical methods;
Keywords: اتانرسپت ; Psoriasis; Clinical equivalence; Meta-analysis; Biologic agents; Infliximab; Ustekinumab; Adalimumab; EtanerceptPsoriasis; Equivalencia clínica; Metaanálisis; Biológicos; Infliximab; Ustekinumab; Adalimumab; Etanercept
Keywords: اتانرسپت ; Rheumatoid arthritis; TNF-α inhibitors; Retention rate; Etanercept; Adalimumab; Infliximab;
Keywords: اتانرسپت ; adalimumab; adherence; claims data; etanercept; golimumab; pharmacoeconomic;
Keywords: اتانرسپت ; Adalimumab; Etanercept; Infliximab; Ustekinumab; Psoriasis; Intensificación; Cambio (switching); Fracaso secundarioAdalimumab; Etanercept; Infliximab; Ustekinumab; Psoriasis; Escalation; Switching; Maintenance failure
Keywords: اتانرسپت ; Adalimumab; Etanercept; Infliximab; Ustekinumab; Psoriasis; Escalation; Switching; Maintenance failureAdalimumab; Etanercept; Infliximab; Ustekinumab; Psoriasis; Intensificación; Cambio (switching); Fracaso secundario
Keywords: اتانرسپت ; Allogeneic stem cell transplantation; Acute GVHD; Steroid refractory; Inolimomab; Etanercept
Survenue d'une fibromatose plantaire active sous traitement par anti-TNFα pour une spondyloarthrite
Keywords: اتانرسپت ; Fibromatose; Maladie de Ledderhose; Ãtanercept; Adalimumab; Inhibiteurs du TNFα; Spondylarthrite ankylosante;
Etanercept restores vasocontractile sensitivity affected by mesenteric ischemia reperfusion
Keywords: اتانرسپت ; Etanercept; Tumor necrosis factor-α receptor; Mesenteric ischemic reperfusion injury; Transactivation;
Contrairement au tocilizumab, l'étanercept augmente légèrement l'agrégation plaquettaire expérimentale induite par la thrombine chez les sujets sains
Keywords: اتانرسپت ; Plaquette; Inflammation; Tocilizumab; Ãtanercept; Polyarthrite rhumatoïde;
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)
Keywords: اتانرسپت ; Adalimumab; Certolizumab pegol; Etanercept; Golimumab; Infection; Infliximab; Prevention; Tuberculosis; Tumour necrosis factor-α;
Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48Â weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT)
Keywords: اتانرسپت ; anti-TNF; anti-tumor necrosis factor; certolizumab pegol; chronic plaque psoriasis; CIMPACT; etanercept; phase 3 trial; CZP; certolizumab pegol; FcRn; neonatal Fc receptor; PASI; Psoriasis Area and Severity Index; PASI 50; â¥50% reduction in PASI from
Improvement of DAS-28 ESR score in Egyptian children and adolescents with juvenile idiopathic arthritis treated with etanercept
Keywords: اتانرسپت ; Juvenile idiopathic arthritis; DAS28-ESR; Anti-tumor necrosis factor-α; Etanercept;
Ãvaluation de l'immunogénicité du vaccin pneumococcique conjugué 13-valent chez des patients atteints de polyarthrite rhumatoïde traités par étanercept
Keywords: اتانرسپت ; Polyarthrite rhumatoïde; Vaccin pneumococcique conjugué; PCV13; Ãtanercept; Taux d'anticorps protecteurs;
Enfermedad inflamatoria intestinal como efecto paradójico del tratamiento con anti-TNF-α
Keywords: اتانرسپت ; Enfermedad inflamatoria intestinal; Efectos paradójicos; Anti-TNF-α; Infliximab; Etanercept; Adalimumab; Inflammatory bowel disease; Paradoxical effects; Anti-TNF-α therapies; Infliximab; Etanercept; Adalimumab;
Transforaminal epidural Etanercept for the treatment of prolapsed lumbar intervertebral disc induced sciatica
Keywords: اتانرسپت ; Transforaminal; Etanercept; Sciatica;
Review articleEfficacy and safety of etanercept in the treatment of sciatica: A systematic review and meta-analysis
Keywords: اتانرسپت ; Etanercept; Sciatica; Lumbar disc herniation; Spinal stenosis; Meta-analysis;
Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumab
Keywords: اتانرسپت ; Rheumatoid arthritis; Soluble VE cadherin; Anti-vascular endothelial-cadherin antibody; Etanercept; Adalimumab;
Tumor necrosis factor-α inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience
Keywords: اتانرسپت ; adalimumab; adverse event; certolizumab; etanercept; golimumab; infliximab; medication side effect; psoriasis; tumor necrosis factor-α-induced psoriasis; tumor necrosis factor-α inhibitor; AS; ankylosing spondylitis; AZA; azathioprine; CD; Crohn disease
Tumor necrosis factor-α antagonist suppresses local inflammatory reaction and facilitates olfactory nerve recovery following injury
Keywords: اتانرسپت ; Cycloheximide; Etanercept; Field potential recording; Olfactory nerve; Regeneration; Tumor necrosis factor-alpha (TNF-α);
Research PaperInflammation-induced GluA1 trafficking and membrane insertion of Ca2Â + permeable AMPA receptors in dorsal horn neurons is dependent on spinal tumor necrosis factor, PI3 kinase and protein kinase A
Keywords: اتانرسپت ; AMPA; α-amino-3-hydroy-5-methyl-4-isoxazolepropionic acid; AMPAr; AMPA receptor; EPSC; excitatory post-synaptic current; ETA; Etanercept; i.t.; intrathecal; LTD; long term depression; LTP; long term potentiation; NMDA; N-methyl-D-aspartic acid; NMDAr; NM
CD3+Â CD56+ natural killer T cell activity in children with different forms of juvenile idiopathic arthritis and the influence of etanercept treatment on polyarticular subgroup
Keywords: اتانرسپت ; Juvenile idiopathic arthritis; Natural killer T cell; Etanercept;
T cell subpopulations in juvenile idiopathic arthritis and their modifications after biotherapies
Keywords: اتانرسپت ; Th17; Nonclassic Th1; CD161; Treg cells; Etanercept;
Development of a sensitive enzyme-linked immunosorbent assay for the measurement of biologically active etanercept in patients with ankylosing spondylitis
Keywords: اتانرسپت ; Ankylosing spondylitis; Biologically active; Enzyme-linked immunosorbent assay; Etanercept; Pharmacokinetics
Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial
Keywords: اتانرسپت ; Graft-versus-host disease; Prophylaxis; Etanercept; Photopheresis